BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17394153)

  • 1. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
    Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
    Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease.
    Kane S; Kisiel J; Shih L; Hanauer S
    Am J Gastroenterol; 2004 Aug; 99(8):1523-6. PubMed ID: 15307871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome.
    Keaveny AP; Gordon FD; Goldar-Najafi A; Lewis WD; Pomfret EA; Pomposelli JJ; Jenkins RL; Khettry U
    Liver Transpl; 2004 Jan; 10(1):115-22. PubMed ID: 14755787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
    Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
    Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Cholongitas E; Shusang V; Papatheodoridis GV; Marelli L; Manousou P; Rolando N; Patch D; Rolles K; Davidson B; Burroughs AK
    Liver Transpl; 2008 Feb; 14(2):138-43. PubMed ID: 18236447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
    Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis.
    Navaneethan U; Choudhary M; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
    Aliment Pharmacol Ther; 2012 May; 35(9):1054-63. PubMed ID: 22428731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary sclerosing cholangitis--an ulcerative colitis-associated illness with surgical consequences].
    Heuschen G; Heuschen UA; Herfarth C
    Chirurg; 1998 Oct; 69(10):1028-34. PubMed ID: 9833181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.
    Navaneethan U; Venkatesh PG; Mukewar S; Lashner BA; Remzi FH; McCullough AJ; Kiran RP; Shen B; Fung JJ
    Clin Gastroenterol Hepatol; 2012 May; 10(5):540-6. PubMed ID: 22245961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients.
    Hoffman JA; Weinberg KI; Azen CG; Horn MV; Dukes L; Starnes VA; Woo MS
    Transpl Infect Dis; 2004 Dec; 6(4):147-55. PubMed ID: 15762932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.